DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 7.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 61.2. According to RSI analysis, drreddy is technically strong. 9.0 DRREDDY RSI Chart
MACD (?) MACD: 36.8 and Signal Line: 34.3. According to MACD analysis, drreddy is technically strong. 8.0 DRREDDY MACD Chart
Simple Moving Average (?) According to simple moving average analysis, drreddy is in a uptrend. Support level is at 2.43e+03. 9.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 200-day exponential moving average which is a positive signal. According to exponential moving average analysis, drreddy is in a uptrend. Support level is at 2.47e+03. 9.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.835. According to bollinger bands, drreddy is technically strong. 7.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 2395.334 and 2352.5. Resistance level is 2534.0. 6.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 53.5 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 21.3 which means DRREDDY is in a trading range and there is no trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 19, 2018
Open Price 2467.0
High Price 2505.0
Low Price 2452.0
Close Price 2490.35
Absolute Change 28.85
Percentage Change 1.17%
Weekly Change 1.74%
Monthly Change 5.89%
Yearly Change -16.6%
52-week high 3177.0
52-week low 1901.15
Corporate Actions
ExDate Purpose
July 17, 2017 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.491
Confidence in Beta1.18%
Market Capital Rs. 42480.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 31.5
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 January 2018: Deliverable Quantity:7.52e+04 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 January 2018: Daily Volatility:0.2732 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 January 2018: PCR_OI:0.508 PCR:0.186 NA DRREDDY PCR Chart
Option Pain (?) 19 January 2018: Max Pain:2450.0 NA DRREDDY Option Pain Chart
Premium (?) 19 January 2018 Premium: 5.2 Futures OI:3617500.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 19 January 2018: Price:2490.35 Put with maximum OI:2300.0 Call with maximum OI:2600.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2018 2495.55 3617500.0 2702.0 3608.0 2490.35
February 22, 2018 2509.25 1366750.0 679.0 1339.0 2490.35
March 28, 2018 2524.0 1500.0 2.0 3.0 2490.35

Announcements

January 16, 2018 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 16, 2018, titled "Dr. Reddy's to release Q3 FY18 results on January 25, 2018 Earnings call slated for January 25, 6.30 PM IST / 8.00 AM EST".
January 08, 2018 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 06, 2018, titled "Dr. Reddy's Laboratories Limited to present at the
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 03, 2018 January 25, 2018 inResultsnter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017.
October 06, 2017 October 31, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2407 Rs. 2429 Rs. 2460 Rs. 2482 Rs. 2513 Rs. 2535 Rs. 2566